Cargando…

Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score

BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Luke, Hittesdorf, Erin, Berman, Mitchell F., Jordan, Desmond A., Yoh, Nina, Elisman, Katerina, Eiseman, Katherine A., Miao, Yuqi, Wang, Shuang, Wagener, Gebhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189812/
https://www.ncbi.nlm.nih.gov/pubmed/34123422
http://dx.doi.org/10.1155/2021/5585291
_version_ 1783705562621411328
author Tseng, Luke
Hittesdorf, Erin
Berman, Mitchell F.
Jordan, Desmond A.
Yoh, Nina
Elisman, Katerina
Eiseman, Katherine A.
Miao, Yuqi
Wang, Shuang
Wagener, Gebhard
author_facet Tseng, Luke
Hittesdorf, Erin
Berman, Mitchell F.
Jordan, Desmond A.
Yoh, Nina
Elisman, Katerina
Eiseman, Katherine A.
Miao, Yuqi
Wang, Shuang
Wagener, Gebhard
author_sort Tseng, Luke
collection PubMed
description BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to deteriorate. METHODS: This is a retrospective cohort study of all COVID-19 patients admitted to a tertiary academic medical center in New York City during the COVID-19 crisis in spring 2020. The primary combined endpoint included intubation, stage 3 acute kidney injury (AKI), or death. Laboratory tests available on admission in at least 70% of patients (and age) were included for univariate analysis. Tests that were statistically or clinically significant were then included in a multivariate binary logistic regression model using stepwise exclusion. 70% of all patients were used to train the model, and 30% were used as an internal validation cohort. The aim of this study was to develop and validate a model for COVID-19 severity based on biomarkers. RESULTS: Out of 2545 patients, 833 (32.7%) experienced the primary endpoint. 53 laboratory tests were analyzed, and of these, 47 tests (and age) were significantly different between patients with and without the endpoint. The final multivariate model included age, albumin, creatinine, C-reactive protein, and lactate dehydrogenase. The area under the ROC curve was 0.850 (CI [95%]: 0.813, 0.889), with a sensitivity of 0.800 and specificity of 0.761. The probability of experiencing the primary endpoint can be calculated as p=e((−2.4475+0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH))/1+e((−2.4475+ 0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH)). CONCLUSIONS: Our study demonstrated that poor outcome in COVID-19 patients can be predicted with good sensitivity and specificity using a few laboratory tests. This is useful for identifying patients at risk during admission.
format Online
Article
Text
id pubmed-8189812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81898122021-06-11 Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score Tseng, Luke Hittesdorf, Erin Berman, Mitchell F. Jordan, Desmond A. Yoh, Nina Elisman, Katerina Eiseman, Katherine A. Miao, Yuqi Wang, Shuang Wagener, Gebhard Crit Care Res Pract Research Article BACKGROUND: COVID-19 may result in multiorgan failure and death. Early detection of patients at risk may allow triage and more intense monitoring. The aim of this study was to develop a simple, objective admission score, based on laboratory tests, that identifies patients who are likely going to deteriorate. METHODS: This is a retrospective cohort study of all COVID-19 patients admitted to a tertiary academic medical center in New York City during the COVID-19 crisis in spring 2020. The primary combined endpoint included intubation, stage 3 acute kidney injury (AKI), or death. Laboratory tests available on admission in at least 70% of patients (and age) were included for univariate analysis. Tests that were statistically or clinically significant were then included in a multivariate binary logistic regression model using stepwise exclusion. 70% of all patients were used to train the model, and 30% were used as an internal validation cohort. The aim of this study was to develop and validate a model for COVID-19 severity based on biomarkers. RESULTS: Out of 2545 patients, 833 (32.7%) experienced the primary endpoint. 53 laboratory tests were analyzed, and of these, 47 tests (and age) were significantly different between patients with and without the endpoint. The final multivariate model included age, albumin, creatinine, C-reactive protein, and lactate dehydrogenase. The area under the ROC curve was 0.850 (CI [95%]: 0.813, 0.889), with a sensitivity of 0.800 and specificity of 0.761. The probability of experiencing the primary endpoint can be calculated as p=e((−2.4475+0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH))/1+e((−2.4475+ 0.02492age − 0.6503albumin+0.81926creat+0.00388CRP+0.00143LDH)). CONCLUSIONS: Our study demonstrated that poor outcome in COVID-19 patients can be predicted with good sensitivity and specificity using a few laboratory tests. This is useful for identifying patients at risk during admission. Hindawi 2021-05-31 /pmc/articles/PMC8189812/ /pubmed/34123422 http://dx.doi.org/10.1155/2021/5585291 Text en Copyright © 2021 Luke Tseng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tseng, Luke
Hittesdorf, Erin
Berman, Mitchell F.
Jordan, Desmond A.
Yoh, Nina
Elisman, Katerina
Eiseman, Katherine A.
Miao, Yuqi
Wang, Shuang
Wagener, Gebhard
Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title_full Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title_fullStr Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title_full_unstemmed Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title_short Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
title_sort predicting poor outcome of covid-19 patients on the day of admission with the covid-19 score
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189812/
https://www.ncbi.nlm.nih.gov/pubmed/34123422
http://dx.doi.org/10.1155/2021/5585291
work_keys_str_mv AT tsengluke predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT hittesdorferin predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT bermanmitchellf predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT jordandesmonda predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT yohnina predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT elismankaterina predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT eisemankatherinea predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT miaoyuqi predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT wangshuang predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score
AT wagenergebhard predictingpooroutcomeofcovid19patientsonthedayofadmissionwiththecovid19score